• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Equifax Inc.

    5/9/25 7:00:21 AM ET
    $EFX
    Finance: Consumer Services
    Finance
    Get the next $EFX alert in real time by email
    8-K
    EQUIFAX INC false 0000033185 0000033185 2025-05-08 2025-05-08
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 8, 2025

     

     

    EQUIFAX INC.

    (Exact Name of Registrant as Specified in Charter)

     

     

     

    Georgia   001-06605   58-0401110

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    1550 Peachtree Street, N.W.

    Atlanta, Georgia

      30309
    (Address of Principal Executive Offices)   (Zip Code)

    Registrant’s telephone number, including area code: (404) 885-8000

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

      ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

      ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

      ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

      ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol

     

    Name of each exchange

    on which registered

    Common stock, $1.25 par value per share   EFX   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.07

    Submission of Matters to a Vote of Security Holders.

    On May 8, 2025, the Company held its 2025 Annual Meeting of Shareholders (the “Annual Meeting”). A total of 114,816,251 shares were represented in person or by valid proxy at the Annual Meeting and the Company’s shareholders took the following actions:

    1. Election of Directors. Shareholders elected ten directors to serve until the next annual meeting of shareholders and until their successors are elected and qualified. The vote totals for each of these individuals is set forth below:

     

    Director

       Shares For      Shares Against      Shares Abstained  

    Mark W. Begor

         109,573,758        382,495        41,687  

    Mark L. Feidler

         105,483,438        4,472,966        41,536  

    Karen L. Fichuk

         109,839,318        103,965        54,657  

    G. Thomas Hough

         108,295,049        1,658,851        44,040  

    Barbara A. Larson

         108,983,742        967,921        46,277  

    Robert D. Marcus

         103,508,766        6,443,309        45,865  

    Scott A. McGregor

         109,707,380        246,088        44,472  

    John A. McKinley

         106,654,706        3,298,922        44,312  

    Melissa D. Smith

         108,306,143        1,588,015        103,782  

    Audrey Boone Tillman

         108,988,194        912,306        97,440  

    There were 4,818,311 broker non-votes with respect to each director nominee listed above.

    2. Advisory Vote to Approve Named Executive Officer Compensation. Shareholders approved, on a non-binding, advisory basis, the compensation paid to the Company’s named executive officers. The vote totals were 101,048,125 shares for, 8,737,307 shares against, 212,508 share abstentions and 4,818,311 broker non-votes.

    3. Ratification of Appointment of Independent Registered Public Accounting Firm. Shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2025. The vote totals were 108,389,739 shares for, 6,381,500 shares against and 45,012 share abstentions.

    4. Approval of Amendments to the Company’s Articles of Incorporation to Eliminate Supermajority Voting Requirements. Shareholders approved amendments to the Company’s Articles of Incorporation to eliminate supermajority voting requirements. The vote totals were 109,616,630 shares for, 306,989 shares against, 74,321 share abstentions and 4,818,311 broker non-votes.


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    EQUIFAX INC.

    By:

     

    /s/ Julia A. Houston

    Name: 

      Julia A. Houston

    Title:

      Executive Vice President and Chief Legal Officer

    Date:

      May 9, 2025
    Get the next $EFX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EFX

    DatePrice TargetRatingAnalyst
    4/10/2025$280.00Buy
    BofA Securities
    4/4/2025$260.00Overweight → Equal Weight
    Barclays
    3/20/2025$300.00Sector Perform → Outperform
    RBC Capital Mkts
    3/14/2025$265.00Outperform → Neutral
    Exane BNP Paribas
    2/11/2025Buy → Hold
    Argus
    12/16/2024$305.00Neutral → Outperform
    Exane BNP Paribas
    12/12/2024Outperform → Peer Perform
    Wolfe Research
    12/12/2024$275.00 → $320.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $EFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities resumed coverage on Equifax with a new price target

      BofA Securities resumed coverage of Equifax with a rating of Buy and set a new price target of $280.00

      4/10/25 12:41:31 PM ET
      $EFX
      Finance: Consumer Services
      Finance
    • Equifax downgraded by Barclays with a new price target

      Barclays downgraded Equifax from Overweight to Equal Weight and set a new price target of $260.00

      4/4/25 8:36:35 AM ET
      $EFX
      Finance: Consumer Services
      Finance
    • Equifax upgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts upgraded Equifax from Sector Perform to Outperform and set a new price target of $300.00

      3/20/25 7:45:38 AM ET
      $EFX
      Finance: Consumer Services
      Finance